1. Home
  2. INAB vs ANY Comparison

INAB vs ANY Comparison

Compare INAB & ANY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • ANY
  • Stock Information
  • Founded
  • INAB 2016
  • ANY N/A
  • Country
  • INAB United States
  • ANY United States
  • Employees
  • INAB N/A
  • ANY N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • ANY Finance: Consumer Services
  • Sector
  • INAB Health Care
  • ANY Finance
  • Exchange
  • INAB Nasdaq
  • ANY Nasdaq
  • Market Cap
  • INAB 23.5M
  • ANY 22.8M
  • IPO Year
  • INAB 2021
  • ANY N/A
  • Fundamental
  • Price
  • INAB $0.36
  • ANY $1.45
  • Analyst Decision
  • INAB Strong Buy
  • ANY Strong Buy
  • Analyst Count
  • INAB 3
  • ANY 1
  • Target Price
  • INAB $7.75
  • ANY $3.00
  • AVG Volume (30 Days)
  • INAB 2.7M
  • ANY 1.2M
  • Earning Date
  • INAB 11-12-2024
  • ANY 11-19-2024
  • Dividend Yield
  • INAB N/A
  • ANY N/A
  • EPS Growth
  • INAB N/A
  • ANY N/A
  • EPS
  • INAB N/A
  • ANY N/A
  • Revenue
  • INAB N/A
  • ANY $25,026,000.00
  • Revenue This Year
  • INAB N/A
  • ANY N/A
  • Revenue Next Year
  • INAB N/A
  • ANY N/A
  • P/E Ratio
  • INAB N/A
  • ANY N/A
  • Revenue Growth
  • INAB N/A
  • ANY 121.94
  • 52 Week Low
  • INAB $0.22
  • ANY $0.57
  • 52 Week High
  • INAB $2.48
  • ANY $4.09
  • Technical
  • Relative Strength Index (RSI)
  • INAB 50.42
  • ANY 62.20
  • Support Level
  • INAB $0.31
  • ANY $1.00
  • Resistance Level
  • INAB $0.37
  • ANY $1.90
  • Average True Range (ATR)
  • INAB 0.04
  • ANY 0.17
  • MACD
  • INAB 0.01
  • ANY 0.05
  • Stochastic Oscillator
  • INAB 38.51
  • ANY 50.00

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Digital Mining and Service and Product. The Digital Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

Share on Social Networks: